Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn how well Liposomal Bupivacaine (Exparel™) controls
post-operative pain in patients undergoing both open and laparoscopic (minimally invasive)
abdominal hernia repair surgery.